Fig. 9From: Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivativesa–c Represents interactions of ligands: (2E,5E)-2-(4-methoxybenzylidene)-5-(4-nitrobenzylidene)cyclopentanone (AK-1a), (1E,4E)-4-(4-nitrobenzylidene)-1-(4-nitrophenyl) oct-1-en-3-one (AK-2a) and beraprost with target: prostacyclin receptor I2 (PG-I2) respectively. d–f Represents interactions of AK-1a, AK-2a and vorapaxar with target: proteinase-activated receptor 1 (PAR-1) respectively, drawn through Biovia Discovery Studio Visualizer client 2016Back to article page